Persistent gut motor dysfunction in a murine model of T-cell-induced enteropathy

Area of Science:

• Gastroenterology
• Immunology
• Pharmacology

Background:

• Inflammatory bowel disease (IBD) patients in remission often exhibit irritable bowel syndrome (IBS)-like symptoms.
• The underlying mechanisms of intestinal muscle hypercontractility during the recovery phase of T-cell-induced enteropathy require investigation.

Purpose of the Study:

• To investigate the mechanisms driving intestinal muscle hypercontractility in the recovery phase of T-cell-induced enteropathy.
• To explore the roles of Th2 cytokines and serotonin (5-HT) in maintaining altered intestinal muscle function.

Main Methods:

• BALB/c mice were treated with anti-CD3 antibody to induce enteropathy.
• Evaluated histological changes, smooth muscle cell contraction, cytokine levels (Th1, Th2, TNF-alpha), and enterochromaffin cell numbers.
• Assessed the role of serotonin by inhibiting its synthesis with PCPA.

Main Results:

• Intestinal tissue damage resolved by day 5 post-treatment.
• Significant smooth muscle hypercontractility was observed from 4 hours and persisted into the recovery phase (day 7).
• Elevated Th2 cytokines (IL-4, IL-13) and increased serotonin-expressing cells were noted from day 1 to day 7. PCPA treatment reduced muscle hypercontractility.

Conclusions:

• Intestinal muscle hypercontractility in remission is maintained at the smooth muscle cell level.
• Th2 cytokines and serotonin play crucial roles in sustaining altered intestinal muscle function during the recovery phase of enteropathy.